GCG and Cognitive impairment: It has been demonstrated that agonists of Glucagon-like peptide-1 (GLP-1) and Cholecystokinin (CCK) receptors improved cognitive deficits, reduced Aβ accumulation, and alleviated mitochondrial damage in 5xFAD mice, by inducing mitophagy [52].